SNDX Operating Cash Flow (Statement)
Syndax Pharmaceuticals Inc · Operating Cash Flow (Statement)
SNDX Operating Cash Flow (Statement)
Latest reported-$30.27Mperiod ending
SNDX Quarterly Cash from Operations (-$1.07K → -$30.27M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SNDX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -30,272,000 | |
| -50,345,000 | |
| -69,488,000 | |
| -70,535,000 | |
| -87,795,000 | |
| -95,162,000 | |
| -57,388,000 | |
| -62,322,000 | |
| -71,645,000 | |
| -83,548,000 | |
| -41,349,000 | |
| -44,653,000 | |
| -35,371,000 | |
| -39,228,000 | |
| -22,894,000 | |
| -28,544,000 | |
| -40,306,000 | |
| -41,931,000 | |
| 100,709,000 | |
| -24,944,000 | |
| -24,045,000 | |
| -22,589,000 | |
| -15,631,000 | |
| -18,297,000 | |
| -21,407,000 | |
| -15,925,000 | |
| -12,727,000 | |
| -8,529,000 | |
| -12,525,000 | |
| -16,831,000 | |
| -15,043,000 | |
| -18,469,000 | |
| -15,149,000 | |
| -19,870,000 | |
| -12,722,000 | |
| -10,181,000 | |
| -11,800,000 | |
| -12,668,000 | |
| -10,416,000 | |
| -11,448,000 | |
| -6,890,000 | |
| -6,403,000 | |
| -4,295,000 | |
| -5,182,000 | |
| -3,996,000 | |
| 11,045,000 | |
| -3,475,000 | |
| -2,602,000 | |
| -3,804,000 | |
| -4,512,000 | |
| -2,756,000 | |
| -2,127,000 | |
| -927,000 | |
| -1,485,000 | |
| -1,065 |